What to do when traditional rescue therapies fail in acute severe ulcerative colitis
- Author:
Christopher F. D. LI WAI SUEN
1
;
Matthew C. CHOY
;
Peter DE CRUZ
Author Information
- Publication Type:Review
- From:Intestinal Research 2024;22(4):397-413
- CountryRepublic of Korea
- Language:English
- Abstract: Acute severe ulcerative colitis (ASUC) is a medical emergency that affects approximately 25% of patients with ulcerative colitis at some point in time in their lives. Outcomes of ASUC are highly variable. Approximately 30% of patients do not respond to corticosteroids and up to 50% of patients do not respond to rescue therapy (infliximab or cyclosporin) and require emergency colectomy. Data are emerging on infliximab dosing strategies, use of cyclosporin as a bridge to slower acting biologic agents and Janus kinase inhibition as primary and sequential therapy. In this review, we outline contemporary approaches to clinical management of ASUC in the setting of failure to respond to traditional rescue therapies.
